WebFilings | EDGAR view
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, DC 20549
_____________________________________________________________________
 
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 
______________________________________________________________________
 
Date of Report (Date of earliest event reported): May 10, 2011
 
BOSTON SCIENTIFIC CORPORATION
(Exact name of registrant as specified in charter)
 
DELAWARE
1-11083
04-2695240
(State or other
(Commission
(IRS employer
jurisdiction of
file number)
identification no.)
incorporation)
 
 
 
One Boston Scientific Place, Natick, Massachusetts
01760-1537
(Address of principal executive offices)
(Zip code)
 
Registrant's telephone number, including area code:   (508) 650-8000
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 

Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
(e)
Approval of Boston Scientific Corporation 2011 Long-Term Incentive Plan
 
At the Annual Meeting of Stockholders (“Annual Meeting”) of Boston Scientific Corporation (the “Company”) held on May 10, 2011, the Company's stockholders approved the Company's 2011 Long-Term Incentive Plan (the “2011 Plan”), which plan will be effective as of June 1, 2011. The Company's Board of Directors (the “Board”) had previously adopted and approved the 2011 Plan on March 1, 2011, subject to stockholder approval. Terms of the 2011 Plan are described in the Company's 2011 Proxy Statement (the “2011 Proxy Statement”), which was filed with the Securities and Exchange Commission (the “SEC”) on March 28, 2011, which description is incorporated herein by reference and is qualified in its entirety by reference to the 2011 Plan. The 2011 Plan is filed as Exhibit 10.1 and is incorporated herein by reference.
 
Approval of Amendment and Restatement of Boston Scientific Corporation 2006 Global Employee Stock Ownership Plan
 
At the Annual Meeting, the Company's stockholders also approved the amendment and restatement of the Company's 2006 Global Employee Stock Ownership Plan (the “GESOP”), which plan will be effective as of July 1, 2011. The Board had previously adopted and approved the amended and restated GESOP on March 1, 2011, subject to stockholder approval. Terms of the amended and restated GESOP are described in the 2011 Proxy Statement, which description is incorporated herein by reference and is qualified in its entirety by reference to the amended and restated GESOP. The amended and restated GESOP is filed as Exhibit 10.2 and is incorporated herein by reference.
 
Item 5.07.
Submission of Matters to a Vote of Security Holders.
 
(a)    As described in Item 5.02 above, the Company held its Annual Meeting on May 10, 2011 in Boston, Massachusetts.
 
(b)    The final voting results on each of the matters submitted to a vote of stockholders at the Annual Meeting are set forth below.
 
(1)
Election of Directors:
 
Director
For
Withheld
Broker Non-Votes
Katharine T. Bartlett
1,136,701,000
 
95,079,198
 
99,587,670
 
Bruce L. Byrnes
1,216,781,778
 
14,998,420
 
99,587,670
 
Nelda J. Connors
1,217,052,025
 
14,728,173
 
99,587,670
 
J. Raymond Elliott
1,216,308,669
 
15,471,529
 
99,587,670
 
Kristina M. Johnson
1,155,068,675
 
76,711,523
 
99,587,670
 
Ernest Mario
1,129,074,670
 
102,705,528
 
99,587,670
 
N.J. Nicholas, Jr.
1,169,303,183
 
62,477,015
 
99,587,670
 
Pete M. Nicholas
1,166,126,481
 
65,653,717
 
99,587,670
 
Uwe E. Reinhardt
1,214,478,493
 
17,301,705
 
99,587,670
 
John E. Sununu
1,216,212,553
 
15,567,645
 
99,587,670
 
 
Accordingly, all of the Company's nominees were elected.
    

 
 

(2)    Advisory Vote on Executive Compensation:
 
For
Against
Abstain
Broker Non-Votes
1,144,647,455
82,186,761
4,945,982
99,587,670
 
Accordingly, the proposal was approved on an advisory basis.
 
(3)    Advisory Vote on Frequency of Future Advisory Votes on Executive Compensation:
 
1 Year
2 Years
3 Years
Abstain
Broker Non‑Votes
1,147,081,436
842,868
79,177,856
4,678,038
99,587,670
 
Accordingly, the frequency of one year received the most votes from stockholders on an advisory basis.
 
(4)    Approval of the Company's 2011 Long-Term Incentive Plan:
 
For
Against
Abstain
Broker Non-Votes
816,016,752
414,942,806
820,640
99,587,670
 
Accordingly, the proposal was approved.
 
(5)    Approval of the amendment and restatement of the Company's 2006 Global Employee Stock Ownership Plan:
 
For
Against
Abstain
Broker Non-Votes
1,220,037,721
11,101,720
640,757
99,587,670
 
Accordingly, the proposal was approved.
 
(6)    Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2011:
 
For
Against
Abstain
1,322,166,027
8,253,389
948,452
 
Accordingly, the proposal was ratified.
 
Item 9.01.
Financial Statements and Exhibits.
 
(d)    Exhibits (# compensatory plans or arrangements)
 
Exhibit No.
Description of Exhibit
10.1
Boston Scientific Corporation 2011 Long-Term Incentive Plan Effective as of June 1, 2011. #
10.2
Boston Scientific Corporation 2006 Global Employee Stock Ownership Plan, Amended and Restated Effective as of July 1, 2011. #
 

 
 

 
 
SIGNATURE
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
BOSTON SCIENTIFIC CORPORATION
 
 
 
 
 
 
 
 
 
Date: May 13, 2011
By:
/s/ Vance R. Brown
 
 
Vance R. Brown
 
 
Vice President and Chief Corporate Counsel
 

 
 

 
 
 
Exhibit No.
Description of Exhibit
10.1
Boston Scientific Corporation 2011 Long-Term Incentive Plan Effective as of June 1, 2011.
10.2
Boston Scientific Corporation 2006 Global Employee Stock Ownership Plan, Amended and Restated Effective as of July 1, 2011.